Severe pre-eclampsia
MONDO:0001641Preeclampsia with a systolic blood pressure of 160 mmHg or higher, or a diastolic blood pressure of 110 mmHg or higher on two occasions at least 4 hours apart while on bedrest. It is associated with thrombocytopenia (platelets less than 100,000 per microliter), impaired liver function (twice normal elevation of hepatic transaminases; severe, persistent right upper quadrant or epigastric pain), progressive renal insufficiency (serum creatinine greater than 1.1 mg/dL or doubling of baseline in the absence of other renal disease), pulmonary edema, or new-onset cerebral or visual disturbances.
Also known as: Preeclampsia with severe features, severe preeclampsia
51 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could cutting salt after childbirth tame dangerous blood pressure?
Disease control Not yet recruitingThis trial tests whether a low-sodium diet can improve blood pressure control in people who had a hypertensive disorder of pregnancy. Participants receive either a provided diet with less than 2000 mg of sodium per day or a standard diet with no salt restrictions for the first we…
Phase: NA • Sponsor: Women and Infants Hospital of Rhode Island • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
A personal guide to better heart health after pregnancy complications
Disease control Not yet recruitingThis study tests whether a patient navigator — a trained staff member who helps connect people with health services — can improve long-term heart health for those who had high blood pressure disorders during pregnancy. About 60 participants will be randomly assigned to receive ei…
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New blood test could prevent dangerous delays in preeclampsia deliveries
Disease control Not yet recruitingThis study tests whether a blood test measuring the sFlt-1/PlGF ratio can help doctors decide the best time to deliver babies in women with severe early-onset preeclampsia. The trial will include 386 pregnant women between 30 and 34 weeks of gestation. Half will have delivery tim…
Phase: NA • Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can remote monitoring and community support tame postpartum high blood pressure?
Disease control Not yet recruitingThis study tests whether combining a Bluetooth blood pressure monitor with regular support from a community health worker can help Black women control high blood pressure after pregnancy. About 404 women will be randomly assigned to either this extra support or standard care. The…
Phase: NA • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a simple mist prevent dangerous blood pressure spikes during C-Sections?
Disease control Not yet recruitingThis study tests whether breathing in a sedative called dexmedetomidine before anesthesia can prevent sudden blood pressure rises during emergency C-sections in women with severe preeclampsia. One hundred participants will be randomly assigned to receive either the drug or a plac…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 26, 2026 16:50 UTC
-
Finger clip could guide fluid treatment in dangerous pregnancy condition
Diagnosis Not yet recruitingThis study looks at whether a noninvasive finger monitor can predict how pregnant women, including those with severe preeclampsia, respond to fluids. Researchers will compare the finger device to standard heart ultrasound in 88 women. The goal is to find a simpler way to guide fl…
Sponsor: Stanford University • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Simple blood test may spot Life-Threatening HELLP syndrome sooner
Diagnosis Not yet recruitingThis study looks at whether a substance in the blood called sCD163 can help doctors find HELLP syndrome early in pregnant women. HELLP is a rare but serious condition that can harm the liver and blood. Researchers will compare sCD163 levels in 70 pregnant women—some with HELLP an…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Vitamin d trial aims to protect pregnant women from Life-Threatening conditions
Prevention Not yet recruitingThis study tests whether taking 2,000 IU of vitamin D daily during pregnancy can prevent preeclampsia, eclampsia, and HELLP syndrome in about 2,000 pregnant women in Uganda. Half the women will receive vitamin D and half a placebo, and researchers will track outcomes up to six we…
Phase: PHASE4 • Sponsor: St Mary's Hospital, Lacor • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Could a safer drug replace magnesium for seizure prevention in pregnancy?
Prevention Not yet recruitingThis study tests whether levetiracetam, a seizure medication, works as well as magnesium sulfate to prevent seizures in pregnant people with severe preeclampsia. About 1,240 participants at 32 weeks or more will be randomly assigned to one of the two drugs. The goal is to see if …
Phase: PHASE3 • Sponsor: Nebraska Methodist Health System • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
Could a simple water pill get moms home faster after severe preeclampsia?
Symptom relief Not yet recruitingThis study tests whether a common water pill (furosemide) can help women with severe preeclampsia recover faster after childbirth and leave the hospital sooner. About 186 women will receive either furosemide or a placebo starting 12 hours after delivery. The goal is to see if the…
Phase: PHASE2 • Sponsor: Universidad Nacional Autonoma de Honduras • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Shorter magnesium dosing studied for postpartum preeclampsia recovery
Knowledge-focused Not yet recruitingThis study looks at how blood test results change after delivery in people with severe preeclampsia. Participants are randomly assigned to receive magnesium for either 12 or 24 hours after birth. The goal is to see if a shorter treatment is safe and effective, and to understand h…
Phase: PHASE4 • Sponsor: Alexander Harrison • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Genetic clues to severe preeclampsia could transform early detection
Knowledge-focused Not yet recruitingThis study investigates genetic and molecular markers in pregnant women with severe preeclampsia, a dangerous condition involving high blood pressure and organ damage. Researchers will analyze blood, urine, and placental samples from 100 women to identify changes in genes and cel…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Why does labetalol fail in severe preeclampsia? new study aims to find out
Knowledge-focused Not yet recruitingSevere preeclampsia is a dangerous pregnancy complication that can cause high blood pressure, harming both mother and baby. This observational study will follow 350 women to identify factors that make blood pressure control with the drug labetalol fail. By understanding these fac…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Morning workouts may tame blood pressure in glaucoma patients
Knowledge-focused Not yet recruitingThis study looks at whether different types of exercise (like walking or strength moves) and timing (morning vs. evening) can safely lower blood pressure in people with glaucoma and high blood pressure. About 60 adults will try four exercise sessions, and their blood pressure and…
Phase: NA • Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Blood markers may predict danger in pregnancy condition
Knowledge-focused Not yet recruitingThis study will check if certain blood markers (like platelet counts and inflammation levels) can help predict serious complications in pregnant women with HELLP syndrome, a rare but dangerous condition. Researchers will follow 60 women to see how these markers relate to problems…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC